Rollins, Inc. ROL
Verdict: Sell. Fair value $32.74 against a price of $59.55 on 6 Jan 2026, 45% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Macro headwinds could impact growth. Valuation multiple compression risk.
Main risks
- Incomplete Financial Data: Key metrics like ROIC and Net Debt/EBITDA rely on proxies for EBIT and assumptions about cash levels, reducing precision.
- Moderate Leverage: While not excessive, a Debt/Equity ratio of 0.61 and Net Debt/EBITDA over 1.1x warrants monitoring, especially in a changing interest rate environment.
- Negative TTM CapEx: The reported TTM CapEx of -$0.03B is anomalous, suggesting asset sales exceeded purchases. This could artificially inflate the TTM FCF figure and may not be sustainable.
- Valuation prices in optimistic scenario (limited margin for error)
- Market volatility
- Execution risk